IDHIFA vs MYLOTARG

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. IDHIFA and MYLOTARG are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	IDHIFA	MYLOTARG
Rating	72/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ENASIDENIB MESYLATE	GEMTUZUMAB OZOGAMICIN
Manufacturer	Bristol Myers Squibb	Wyeth Pharms Inc
Dosage forms	Tablet	Injectable
Drug class	Isocitrate Dehydrogenase 2 Inhibitor	Cd33-Directed Immunoconjugate
Boxed warning	Boxed warning	Boxed warning
Treats	Acute Myeloid Leukemia	Acute Myeloid Leukemia, Acute Myelomonocytic Leukemia

idhifa mylotarg

Rating

72/100

New

Pharmacy pays

—

Type

Active ingredient

ENASIDENIB MESYLATE

GEMTUZUMAB OZOGAMICIN

Manufacturer

Bristol Myers Squibb

Wyeth Pharms Inc

Dosage forms

Tablet

Injectable

Drug class

Isocitrate Dehydrogenase 2 Inhibitor

Cd33-Directed Immunoconjugate

Boxed warning

Treats

Acute Myeloid Leukemia

Acute Myeloid Leukemia, Acute Myelomonocytic Leukemia

Frequently asked questions

What is the difference between Idhifa and Mylotarg?

Idhifa contains Enasidenib Mesylate, while Mylotarg contains Gemtuzumab Ozogamicin — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.